Nagayama Y, Tajiri J, Murakami T, Watanabe N, Sato S, Shindo H, Tachibana S, Attanasio R, Papini E, Perros P, Nagy EV, Hegedüs L, Ito K, Yamashita H.
A questionnaire survey of thyroid specialists in Japan on the use of thyroid hormones in hypothyroid and euthyroid patients.
Endocr J. 2025 Jun 10. doi: 10.1507/endocrj.EJ25-0106
Murakami T, Higaki N, Nishijima Y, Tani J, Noguchi H, Eto M.
Goiter index: an easily available ultrasonographic index for thyroid volume in autoimmune thyroid diseases.
Endocr J. 2025 Jun 3. doi: 10.1507/endocrj.EJ25-0070
Sato M, Kubota R, Uchino S , Morita T, Niikuni R, Udagawa T, Hagiwara Y, Tanaka M, Sato M, Tezuka Y, Omata K, Ono Y, Haginoya K, Nakashima N, Fujimori K, Ishida T.
p.M918W, a novel RET germline variant: a case report and literature review of the possible association of multiple endocrine neoplasia type 2B and Charcot-Marie-Tooth disease.
Endocr J. 2025 Apr 1. doi: 10.1507/endocrj.EJ24-0412
Nishijima Y, Murakami T, Higaki N, Tani J, Noguchi H.
The prognosis of severe subclinical hyperthyroidism with TSH below 0.1 μU/mL due to Graves’ disease in the Japanese population.
Endocr J. 2025 Feb 26. doi: 10.1507/endocrj.EJ24-0424
Kikuchi S, Tani J, Murakami T.
Low echogenicity of Hashimoto’s disease could be useful in detecting early phase of thyroid lymphomas, especially diffuse large B cell lymphomas.
Thyroid Science. 1(4): 100020, 2024. doi: 10.1016/j.thscie.2024.100020
Murakami T, Higaki N, Nishijima Y, Tani J, Noguchi H, Morisaki M, Eto M, Tani Y.
An easy approach to ultrasonographic volumetry of the thyroid.
Endocr J. 71(6): 617-621, 2024. doi: 10.1507/endocrj.EJ23-0606
Arimitsu H, Nishijima Y, Higaki N, Noguchi H, Uchino S, Murakami T.
A case report of anaplastic thyroid carcinoma transformed from small papillary carcinoma successfully detected by ultrasonography in its early stage with review of literature.
Endocr J. 70(11): 1097-1101, 2023. doi: 10.1507/endocrj.EJ23-0197
Shah R, Sehemby M, Garg R, Purandare N, Hira P, Mahajan A, Lele V, Malhotra G, Verma P, Rojekar A, Dalvi A, Uchino S, Rastogi S, Lila A, Patil V, Shah N, Bandgar T.
68 Ga-DOTATATE PET/CT imaging in endogenous hyperinsulinemic hypoglycemia: A tertiary endocrine centre experience.
Clin Endocrinol (Oxf). 96(2): 190-199, 2022. doi: 10.1111/cen.14586
Fukushima M, Fukunari N, Murakami T, Kunii Y, Suzuki S, Kitaoka M.
Reconfirmation of the accuracy of the taller-than-wide sign in multicenter collaborative research in Japan.
Endocr J. 68(8): 897-904, 2021. doi: 10.1507/endocrj.EJ20-0379
Matsushita R, Sakurai A, Minamitani K, Yamazaki M, Uchino S.
Extra-endocrine phenotypes at infancy in multiple endocrine neoplasia type 2B: A case series of six Japanese patients.
Clin Pediatr Endocrinol. 30(4): 195-200, 2021. doi: 10.1297/cpe.30.195
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
J Gastroenterol. 56(11): 1033-1044, 2021. doi: 10.1007/s00535-021-01827-7
Shimura H, Matsumoto Y, Murakami T, Fukunari N, Kitaoka M, Suzuki S.
Diagnostic strategies for thyroid nodules based on ultrasonographic findings in Japan.
Cancers. 13(18): 4629, 2021. doi: 10.3390/cancers13184629
Shah R, Gosavi V, Mahajan A, Sonawane S, Hira P, Kurki V, Bal M, Sathe P, Pai P, D’Cruz A, Uchino S, Garale MN, Patil V, Lila A, Shah N, Bandgar T.
Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort.
Head Neck. 43(7): 2069-2080, 2021. doi: 10.1002/hed.26677
Nakakura S, Hosomichi K, Uchino S, Murakami A, Oka A, Inoue I, Nakaoka H.
HLA-B*39:01:01 is a novel risk factor for antithyroid drug-induced agranulocytosis in Japanese population.
Pharmacogenomics J. 21(1): 94-101, 2021. doi: 10.1038/s41397-020-00187-4